MAP3K7CL antibody (AA 151-200)
Quick Overview for MAP3K7CL antibody (AA 151-200) (ABIN203427)
Target
See all MAP3K7CL AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 151-200
-
Specificity
- Human C21orf7
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human, Guinea pig (100%) Horse (92%).
-
Purification
- Protein A purified
-
Immunogen
-
Synthetic peptide located between aa151-200 of human MAP3K7CL (P57077, NP_064537). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Galago, Marmoset, Mouse, Rat, Hamster, Elephant, Bovine, Rabbit, Guinea pig (100%), Dog, Horse (92%), Lizard, Xenopus (83%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: IHC, IHC-P, WB (1.25 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- MAP3K7CL (MAP3K7 C-Terminal Like (MAP3K7CL))
-
Alternative Name
- MAP3K7CL / TAK1L
-
Background
-
Name/Gene ID: MAP3K7CL
Synonyms: MAP3K7CL, HC21ORF7, MAP3K7 c-terminal like, TAK1-like protein, TAK1-like protein 2, TAKL, TAKL-2, TGF-beta activated kinase, TAKL-4, TAK1L, C21orf7, TAK1-like protein 1, TAK1-like protein 4, TAKL-1 -
Gene ID
- 56911
-
NCBI Accession
- NP_064537
-
UniProt
- P57077
Target
-